编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 08:30-08:50 |
肿瘤心脏病学国内外现状与展望 |
夏云龙 | 大连医科大学附属第一医院 |
Current status and future direction of cardio-oncology in China |
Yunlong Xia | The First Affiliated Hospital of Dalian Medical University | ||
2 | 08:50-09:10 |
免疫检查点抑制剂相关性心肌炎:发生机制、临床特点和管理策略 |
陈样新 | 中山大学孙逸仙纪念医院 |
Immune checkpoint inhibitors-related myocarditis: mechanisms, clinical characteristics and therapeutic strategies |
Yangxin Chen | Sun Yat-sen Memorial Hospital, Sun Yat-sen University | ||
3 | 09:10-09:30 |
抗肿瘤靶向TKI药物心脏损伤研究进展 |
申鹏 | 南方医科大学南方医院 |
Research progress in heart injury of anti-tumor targeted TKI drugs |
Peng Shen | |||
4 | 09:30-09:50 |
抗肿瘤治疗相关心功能不全:发生机制、临床特点和管理策略 |
林立 | 华中科技大学同济医学院附属同济医院 |
Cardiac insufficiency associated with cancer therapies: mechanisms, clinical characteristics and therapeutic strategies |
Li Lin | |||
5 | 09:50-10:10 |
肿瘤相关高血压的诊断与管理 |
刘彤 | 天津医科大学第二医院 |
Cancer-related hypertension: diagnosis and management |
Tong Liu | Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University |
编号 | 时间 | 题目 | 讲者 | 单位 |
---|---|---|---|---|
1 | 10:10-10:30 |
肿瘤患者行心导管介入治疗的适应症选择 |
李悦 | 哈尔滨医科大学附属第一医院 |
Cardio-Oncology patients in the cardiac catheterization laboratory |
Yue Li | The 1st Affiliated Hospital of Harbin Medical University | ||
2 | 10:30-10:50 |
肿瘤治疗相关心律失常的分子机制 |
凃欣 | 华中科技大学 |
Molecular mechanisms of arrhythmias associated with cancer therapies |
Xin Tu | Huazhong University of Science and Technology | ||
3 | 10:50-11:10 |
抗肿瘤治疗相关室性心律失常:发生机制、临床特点和管理策略 |
王礼春 | 中山大学附属第一医院 |
Ventricular arrhythmias associated with cancer therapies: mechanisms, clinical characteristics and therapeutic strategies |
Lichun Wang | Guangdong General hospital | ||
4 | 11:10-11:30 |
免疫治疗心脏毒性临床研究进展 |
蔡修宇 | 中山大学肿瘤防治中心 |
Progress in clinical research of cardiac toxicity by immunotherapy |
Xiuyu Cai | Cancer Center of Sun Yat-sen University | ||
5 | 11:30-11:50 |
心脏肿瘤的超声表现 |
费洪文 | 广东省心血管病研究所 |
Echocardiographic manifestations of cardiac tumor |
Hongwen Fei | Guangdong Cardiovascular Institute |